Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.78 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.78 |
| ▸ | AR | P10275 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.78 |
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | TST | Q16762 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.68 |
| ▸ | VDR | P11473 | 4/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 25-Hydroxyergocalciferol- SCHEMBL15981129 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL19469428 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL15981131 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL10034123 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL285346 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL9933379 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL12464610 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL17274134 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL1879846 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL9933381 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150272967-A1 | EXTREMELY HIGH LOADING DOSE | GRASSO FRANK J (US) | 2015-10-01 | — | — | US | claimed |
| WO-2015102996-A1 | EXTREMELY HIGH LOADING DOSE | GRASSO FRANK J (US) | 2015-07-09 | — | — | WO | claimed |
| EP-1695095-B1 | METHOD FOR THE DETERMINATION OF 25-HYDROXYCHOLECALCIFEROL IN FEED | DSM IP ASSETS BV (NL) | 2010-10-20 | — | — | EP | claimed |
| US-20090088373-A1 | USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE | BVR TECHNOLOGIES CO. | 2009-04-02 | — | — | US | claimed |
| US-7358092-B2 | Method for the determination of 25-hydroxycholecalciferol in feed | DSM IP ASSETS B.V. (NL) | 2008-04-15 | — | — | US | claimed |
| US-20080038374-A1 | New Use | LIPOPEPTIDE AB (SE) | 2008-02-14 | — | — | US | claimed |
| US-20070117209-A1 | Radio-labeled analyte; aqueous dispersion; liquid chromatography, mass spectrometry | DSM IP ASSETS B.V. (NL) | 2007-05-24 | — | — | US | claimed |
| EP-1695095-A2 | METHOD FOR THE DETERMINATION OF 25-HYDROXYCHOLECALCIFEROL IN FEED | DSMIP Assets B.V. (NL) | 2006-08-30 | — | — | EP | claimed |
| WO-2005059565-A2 | METHOD FOR THE DETERMINATION OF 25-HYDROXYCHOLECALCIFEROL IN FEED | DSM IP ASSETS B.V. (NL) | 2005-06-30 | — | — | WO | claimed |
| EP-0710112-B1 | Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss | UNIV KENTUCKY (US) | 2001-12-05 | — | — | EP | claimed |
| US-5939407-A | VITAMIN D RECEPTORS FOR NERVOUS SYSTEM DISORDERS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 1999-08-17 | — | — | US | claimed |
| EP-0710112-A1 | Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss | BOARD OF TRUSTEES OF THE UNIVERSITY OF KENTUCKY (US) | 1996-05-08 | — | — | EP | claimed |
| WO-1995002409-A2 | USE OF VITAMIN D AND DERIVATIVES THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR PROTECTION AGAINST NEURON LOSS | BOARD OF TRUSTEES OF THE UNIVERSITY OF KENTUCKY (US) | 1995-01-26 | — | — | WO | claimed |
| US-4330537-A | PHOSPHONATE COMPOUNDS AND VITAMIN D DERIVATIVES USEFUL AGAINST OSTEOPORSIS | THE PROCTER & GAMBLE COMPANY (US) | 1982-05-18 | — | — | US | claimed |
| US-4310522-A | THICKENED EGG SHELLS COMPRISING CALCIUM SOURCE AND A HYDROXY CHOLECALCIFEROL | THE UPJOHN COMPANY (US) | 1982-01-12 | — | — | US | claimed |
| US-4230700-A | ADMINISTERING AN ORGANIC MONO- OR DIPHOSPHONATE AND A VITAMIN-D-LIKE ANTIRACHITIC COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1980-10-28 | — | — | US | claimed |
| US-4012509-A | HYDROXY-CHOLECALCIFEROLS, -TACHYSTEROLS, -ERGOCALCIFEROLS AND THEIR ACYLATES; EGG SHELL THICKNESS | THE UPJOHN COMPANY (US) | 1977-03-15 | — | — | US | claimed |
| US-20250235528-A1 | VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST | ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL (SE) | 2025-07-24 | — | — | US | disclosed |
| US-4310522-A | THICKENED EGG SHELLS COMPRISING CALCIUM SOURCE AND A HYDROXY CHOLECALCIFEROL | THE UPJOHN COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4012509-A | HYDROXY-CHOLECALCIFEROLS, -TACHYSTEROLS, -ERGOCALCIFEROLS AND THEIR ACYLATES; EGG SHELL THICKNESS | THE UPJOHN COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088373-A1 | USE OF COMPOSITIONS TO ENHANCE INNATE IMMUNE RESPONSE | MYD88, MTOR, TLR3 | ALDH1A1 4871/4885ALOX15 1052/4885CYP3A4 3157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.